Dxcover Limited

Dxcover is a clinical-stage diagnostics company developing multiomic spectral analysis (MOSA-Dx™) for early detection of solid tumor cancers. The company's technology utilizes AI to analyze liquid samples, with a quick turnaround time, enabling early-stage detection of various solid tumors.

Funding Round:

Funding Amount: $6.2M

Date: 03-Feb-2025

Investors: Eos Advisory, SIS Ventures, University of Strathclyde, Norcliffe Capital, Maven Capital Partners, Macmillan Cancer Support

Markets: Healthtech, Health Care, Biotechnology, Machine Learning, Medical, Health Diagnostics

HQ: Glasgow, Scotland, United Kingdom

Founded: 2016

Website: https://www.dxcover.com/

LinkedIn: https://www.linkedin.com/company/dxcover-ltd

Twitter: https://twitter.com/DxcoverLtd

Instagram:

Facebook: https://www.facebook.com/dxcoverltd